Document Detail


Growth factors rapidly induce expression of the glucose transporter gene.
MedLine Citation:
PMID:  3262104     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The expression of the gene encoding the facilitated glucose transporter (GT) protein was studied in fibroblast cell lines. Addition of 15% calf serum to confluent BALB/c3T3, NIH3T3, or Rat-2 cells rapidly induced a 5-10-fold increase in GT mRNA, as determined by hybridization of size-fractionated total RNA to a rat brain GT cDNA. The rise in GT mRNA was maximal at 3-4 h after stimulation, and then returned to basal values by 16 h. The serum-stimulated increase in GT mRNA was not blocked by the protein synthesis inhibitors cycloheximide (10 micrograms/ml) or anisomycin (100 microM). In BALB/c3T3 cells, fibroblast growth factor (100 ng/ml), platelet-derived growth factor (5 units/ml), and epidermal growth factor (40 ng/ml) stimulated GT mRNA accumulation, although, when added individually, none of these growth factors increased DNA synthesis. The tumor promoter 12-O-tetradecanoyl phorbol-13-acetate (TPA), which activates the enzyme protein kinase C, also caused GT mRNA accumulation in BALB/c3T3 and NIH3T3 cells. Prolonged pretreatment of cells with TPA abolished the response to TPA but not fibroblast growth factor. The involvement of GT gene transcription was assessed by the nuclear run-on technique. Treatment of NIH3T3 cells with serum increased transcription at least 10-20-fold by 30 min and returned to near basal levels by 2 h. This rapid activation paralleled that of the c-fos gene, but preceded the increase in c-myc gene transcription. These data indicate the following: 1) serum growth factors increase glucose transporter mRNA levels by a process not requiring intermediary new protein synthesis and clearly dissociable from mitogenesis, 2) the changes in GT mRNA are preceded by a rapid and transient activation of GT gene transcription, and 3) there exist protein kinase C-dependent and independent pathways for regulation of GT gene expression.
Authors:
Y Hiraki; O M Rosen; M J Birnbaum
Related Documents :
16107734 - Survival signals generated by estrogen and phospholipase d in mcf-7 breast cancer cells...
7556624 - Prothymosin alpha mrna levels vary with c-myc expression during tissue proliferation, v...
1374614 - Evidence for post-transcriptional regulation of cytokeratin gene expression in a rat li...
1906344 - Transcriptional deregulation of myc in igh/myc 6;7 translocation carrying rat immunocyt...
18813944 - Integrin-linked kinase cytoplasmic and nuclear expression in laryngeal carcinomas.
17720484 - Analysis of small rna profiles during development.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of biological chemistry     Volume:  263     ISSN:  0021-9258     ISO Abbreviation:  J. Biol. Chem.     Publication Date:  1988 Sep 
Date Detail:
Created Date:  1988-10-19     Completed Date:  1988-10-19     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  2985121R     Medline TA:  J Biol Chem     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  13655-62     Citation Subset:  IM    
Affiliation:
Department of Cellular and Molecular Physiology, Harvard Medical School, Boston, Massachusetts 02115.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anisomycin / pharmacology
Blood
Cell Line
Cycloheximide / pharmacology
DNA / genetics
Epidermal Growth Factor / pharmacology
Fibroblast Growth Factors / pharmacology
Gene Expression Regulation* / drug effects
Growth Substances / pharmacology*
Kinetics
Mice
Monosaccharide Transport Proteins / genetics*
Nucleic Acid Hybridization
Platelet-Derived Growth Factor / pharmacology
RNA, Messenger / biosynthesis
Rats
Tetradecanoylphorbol Acetate / pharmacology
Transcription, Genetic / drug effects
Grant Support
ID/Acronym/Agency:
AM35158/AM/NIADDK NIH HHS; DK35430/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Growth Substances; 0/Monosaccharide Transport Proteins; 0/Platelet-Derived Growth Factor; 0/RNA, Messenger; 16561-29-8/Tetradecanoylphorbol Acetate; 22862-76-6/Anisomycin; 62031-54-3/Fibroblast Growth Factors; 62229-50-9/Epidermal Growth Factor; 66-81-9/Cycloheximide; 9007-49-2/DNA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hemorrhagic necrotizing enterocolitis associated with Clostridium difficile infection in four foals.
Next Document:  Platelet-activating factor-induced homologous and heterologous desensitization in cultured vascular ...